Association between mRNA vaccination and COVID-19 hospitalization and disease severity

…, DJ Douin, HK Talbot, JD Casey, NM Mohr, A Zepeski… - Jama, 2021 - jamanetwork.com
Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective …

…, DJ Douin, HK Talbot, JD Casey, NM Mohr, A Zepeski… - bmj, 2022 - bmj.com
Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …

[HTML][HTML] Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States

…, DJ Douin, HK Talbot, JD Casey, NM Mohr, A Zepeski… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

…, AA Ginde, T McNeal, HK Talbot, JD Casey, A Zepeski… - Bmj, 2022 - bmj.com
Objective To compare the effectiveness of a primary covid-19 vaccine series plus booster
doses with a primary series alone for the prevention of hospital admission with omicron related …

Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United …

…, JD Casey, NM Mohr, A Zepeski… - Clinical infectious …, 2022 - academic.oup.com
Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination coverage increases in the United States, there is a need to understand the real-world …

[HTML][HTML] Clinical severity and mRNA vaccine effectiveness for omicron, delta, and alpha SARS-CoV-2 variants in the United States: a prospective observational study

…, DJ Douin, HK Talbot, JD Casey, NM Mohr, A Zepeski… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objectives To characterize the clinical severity of COVID-19 caused by Omicron, Delta, and
Alpha SARS-CoV-2 variants among hospitalized adults and to compare the effectiveness of …

mRNA vaccine effectiveness against coronavirus disease 2019 hospitalization among solid organ transplant recipients

…, JD Casey, NM Mohr, A Zepeski… - The Journal of …, 2022 - academic.oup.com
Background The study objective was to evaluate 2- and 3-dose coronavirus disease 2019 (COVID-19)
mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among …

[HTML][HTML] Vaccine effectiveness of primary series and booster doses against Omicron variant COVID-19-associated hospitalization in the United States

…, D Huynh, HK Talbot, JD Casey, NM Mohr, A Zepeski… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objectives: To compare the effectiveness of a primary COVID-19 vaccine series plus a
booster dose with a primary series alone for the prevention of Omicron variant COVID-19 …

Effectiveness of mRNA vaccines against COVID-19 hospitalization by age and chronic medical conditions burden among immunocompetent US adults, March-August …

…, JD Casey, NM Mohr, A Zepeski… - The Journal of …, 2022 - academic.oup.com
Vaccine effectiveness (VE) against COVID-19 hospitalization was evaluated among
immunocompetent adults (≥18 years) during March–August 2021 using a case-control design. …

High prevalence of fluoroquinolone‐resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020

…, G Slocum, D Zimmerman, A Zepeski… - Academic …, 2022 - Wiley Online Library
Background Uropathogen resistance, fluoroquinolone‐resistance (FQR), and extended
spectrum beta‐lactamase (ESBL), has been observed to be emerging worldwide with …